Medicinal Chemistry of Antiviral Drugs

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/90

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

91 Terms

1
New cards

What are good antiviral drug targets?

  • efficient - important to the life cycle of the virus

  • selective and safe - bear little resemblance to human proteins

  • broad spectrum - common to a variety of different viruses

  • important to the early stages of the viral life cycle

2
New cards

Which viruses are DNA viruses?

  • herpes simplex virus 

    • type 1 infection - mouth, face, skin, brain

    • type 2 infection - genitals, rectum, skin, hands, meninges 

  • varicella-zoster virus 

    • chickenpox in children

    • shingles in adults

  • cytomegalovirus 

    • life-threatening for immunocompromised patients 

3
New cards

What are the types of drugs used to treat DNA viruses?

  • viral DNA polymerase inhibitor 

  • tubulin polymerization inhibitor 

4
New cards

What is the role of nucleoside triphosphate in DNA replication?

  • they serve as building blocks for forming a new DNA strand using a DNA template which is catalysed by DNA polymerase 

5
New cards

What enzyme catalyses the formation of new DNA strands during replication?

  • DNA polymerase 

6
New cards

Why are nucleoside analogues used in antiviral therapy?

  • effective against DNA virus

    • especially herpes viruses 

7
New cards

How do nucleoside analogues inhibit DNA polymerase?

  • mimics natural nucleosides

  • they get incorporated into viral DNA and terminate chain elongation 

8
New cards

Why are herpes viruses particularly susceptible to nucleoside analogues?

  • they rely heavily on viral DNA polymerase for replication which the nucleoside analogues target 

9
New cards

What type of drug is acyclovir?

  • a nucleoside analogue

10
New cards

Which natural nucleoside does aciclovir resemble and what structure does aciclovir lack compared to the natural nucleoside?

  • resembles deoxyguanosine 

  • it lacks the complete sugar ring

11
New cards

How is aciclovir activated in the body?

  • phosphorylated in three stages to form the active triphosphate form 

12
New cards

What is the mechanism of action of acyclovir triphosphate?

  • inhibits viral DNA polymerase and causes chain termination during DNA replication

13
New cards

How to nucleoside analgouses cause chain termination?

  • they incorporate into growing DNA strand but lack a 3’-OH group which prevents further elongation

14
New cards

Why is aciclovir selectively taken up by infected cells?

  • infected cells have mechanisms that absorb aciclovir over healthy cells

15
New cards

What enzyme activates acyclovir in infected cells?

  • viral thymidine kinase 

    • 100 x more effective than host thymidine kinase

    • phosphorylates aciclovir to its monophosphate form, initiates activation

16
New cards

What are the uses for acyclovir?

  • herpes simplex 1 and 2 infections

  • varicella zoster virus

17
New cards

Is acyclovir active against all herpes types?

  • no due to mutation in thymidine kinase or DNA polymerase enzymes 

  • also not effective in Cytomegaloviruses it has no viral thymidine kinase 

    • which is needed to activate acyclovir

18
New cards

Why does acyclovir have low oral bioavailability?

  • due to poor intestinal permeability 

  • only 15-30% is absorbed 

  • therefore prodrugs are used to increase interstinal permeability

19
New cards

What is Valaciclovir and how does it enhance bioavailability?

  • an l-valyl ester prodrug of acyclovir which is designed to improve absorption 

  • uses active transport via HP1-1 protein which increases bioavailability to 54%

20
New cards

Where is Valaciclovir converted to Aciclovir?

  • in liver and gut wall through hydrolysis 

21
New cards

What is the clinical use of valacyclovir?

  • varicella-zoster virus 

22
New cards

What is ganciclovir used to treated?

  • Cytomegalovirus (CMV) infections.

23
New cards

How is Ganciclovir activated in CMV-infected cells?

  • By kinases other than thymidine kinase, converting it to its monophosphate form.

24
New cards

Why does Ganciclovir have low oral bioavailability?

  • It is highly polar, leading to poor intestinal permeability.

25
New cards

What is Valganciclovir and how does it improve bioavailability?

  • It is a valyl prodrug of Ganciclovir that enhances absorption via active transport mechanisms.

26
New cards

What type of drug is podophyllotoxin and where is it derived from?

  • Tubulin polymerization Inhibitor

  • plant-derived product

27
New cards

What is Podophyllotoxin used to treat?

  • Genital warts caused by the DNA virus papillomavirus.

28
New cards

What are the two main actions of Podophyllotoxin?

  • Antiviral and antimitotic.

29
New cards

How does Podophyllotoxin exert its antimitotic effect?

  • By inhibiting tubulin polymerization, disrupting microtubule formation during cell division.

30
New cards

What are the challenges in treating HIV?

  • no vaccination available 

    • as virus keeps mutating

  • antiviral drugs slow disease but don’t eradicate disease 

  • virus undergoes many mutations easily 

    • this results in rapid resistance to antiviral drugs 

31
New cards

What are the key enzymes involved in the HIV life cycle and what are their roles?

  • reverse transcriptase

    • catalyses synthesis of DNA strand using viral RNA as template = RNA/DNA template 

    • then it catalyses the degradation of RNA strand 

    • uses remaining DNA strand as template to catalyse the synthesis of dsDNA 

  • integrase

    • inserts viral DNA into host cell’s DNA

  • protease

    • cleaves polyproteins into functional viral proteins for assembly 

32
New cards

What type of antiviral drugs are used to treat HIV?

  • reverse transcriptase inhibitors 

  • protease inhibitors 

  • integrase inhibitors 

  • fusion inhibitors 

33
New cards

Why is reverse transcriptase a key drug target in HIV treatment, and what challenge does it present?

  • unique to HIV - ideal for selective inhibition  

Challenge:

  • its still a DNA polymerase so there is risk of cross inhibition with host cellular DNA polymerases therefore drug design must balance potency against HIV with minimal toxicity to host cells

34
New cards

What are the types of reverse transcriptase inhibitors?

  • nucleoside reverse transcriptase inhibitors (NRTIs)

  • non-nucleoside reverse transcriptase inhibitors (NNRTIs)

35
New cards

How do NRTIs become active and why is this activation necessary?

  • they are phosphorylated by 3 cellular enzymes which forms an active nucleoside triphosphate a

  • this is necessary as HIV lacks a viral kinase so it relies on host enzyme for activation 

36
New cards

What structural modification makes Zidovudine a chain terminator?

  • The 3'-OH group in deoxythymidine is replaced by an azido group (N₃), preventing DNA chain elongation

<ul><li><p>The 3'-OH group in deoxythymidine is replaced by an azido group (N₃), preventing DNA chain elongation</p></li></ul><p></p>
37
New cards

How does Zidovudine inhibit HIV replication?

  • once phosphorylated to its triphosphate form it inhibits reverse transcriptase and terminates DNA synthesis by attaching to growing DNA chain by terminating the chain 

38
New cards

Why is Zidovudine considered selective for HIV?

  • It has greater affinity for viral reverse transcriptase than for human DNA polymerase.

39
New cards

What are potential side effects of Zidovudine?

  • anemia

40
New cards
41
New cards

What structural change is common to Lamivudine and Emtricitabine?

  • both replace the 3' carbon in the sugar ring with sulfur, preventing DNA chain elongation.

42
New cards

What distinguishes Lamivudine from Emtricitabine chemically?

  • Lamivudine has R = H

  • Emtricitabine has R = F.

<ul><li><p>Lamivudine has R = H</p></li><li><p>Emtricitabine has R = F.</p></li></ul><p></p>
43
New cards

How do deoxycytidine analogues inhibit HIV replication?

  • After phosphorylation to triphosphate form, they inhibit reverse transcriptase and act as chain terminators.

44
New cards

Which deoxycytidine analogue is also approved for hepatitis B treatment?

  • lamivudine 

45
New cards

Why do deoxycytidine analogues act as chain terminators?

  • they lack a 3'-OH group in the sugar ring, so DNA synthesis cannot continue.

46
New cards

Why are NNRTIs considered less toxic than NRTIs?

  • NNRTIs have higher selectivity for HIV-1 reverse transcriptase over host DNA polymerases → fewer side effects

47
New cards

What is a major limitation of NNRTIs in HIV treatment?

  • Rapid resistance can develop due to mutations in the NNRTI binding site.

48
New cards

Why are NNRTIs and NRTIs often combined in HIV therapy?

  • Combining from the start reduces resistance risk; they bind to distinct sites on reverse transcriptase.

49
New cards

Do NNRTIs require phosphorylation for activation like NRTIs?

  • NNRTIs bind directly to reverse transcriptase without needing phosphorylation.

50
New cards

What are the first generation NNRTIs?

  • nevirapine

  • delavirdine

  • efavirenz 

51
New cards

What are the second generation NNRTIs?

  • etravirine 

  • rilpivirine 

52
New cards

What structural feature and binding interactions define Nevirapine as a first generation NNRTI?

  • rigid butterfly like conformation 

  • interacts with HIV-1 reverse transcriptase at key residues  

53
New cards

What is nevirapine a derivative?

  • Dipyridino-diazepine derivative

54
New cards

How does Nevirapine’s left wing interact with HIV-1 reverse transcriptase?

  • it binds to aliphatic residues: Leu-100, Val-106, Val-179.

55
New cards

What interactions occur at Nevirapine’s right wing?

  • Hydrophobic and van der Waals interactions with aromatic residues: Tyr-181, Tyr-188.

56
New cards

Why is Nevirapine vulnerable to resistance?

  • Mutations at its binding residues (e.g., Tyr-181, Tyr-188) can disrupt its interaction with reverse transcriptase.

57
New cards

What does the rigid butterfly-like conformation of Nevirapine imply for drug design?

  • Enhances binding specificity (potency) but limits flexibility, making it more susceptible to resistance mutations.

58
New cards

What is metabolic autoinduction in the context of Nevirapine?

  • Nevirapine induces its own metabolism, reducing its half-life from 45 to 23 hours after 2–4 weeks.

59
New cards

Why is Nevirapine combined with NRTIs in HIV therapy?

  • to prevent resistance development, as NNRTIs alone are prone to rapid resistance.

60
New cards

What was the primary goal in developing second-generation NNRTIs?

  • To target both wild-type HIV and variants resistant to first-generation NNRTIs.

61
New cards

Name two second-generation NNRTIs and their brand names and what chemical class do they belong to?

  • Etravirine (Intelence)

  • Rilpivirine (Edurant)

  • chemical class - Diarylpyrimidine (DAPY) derivatives.

62
New cards

How do second-generation NNRTIs improve resistance handling?

  • their flexible structures allow better accommodation of mutations in the reverse transcriptase binding site.

63
New cards

What enzyme family does HIV-Protease belong to?

  • Aspartyl proteases.

64
New cards

Describe the structural composition of HIV-Protease?

  • symmetrical dimer of two identical subunits (99 amino acids each), resembling an English bulldog face.

65
New cards

What makes the HIV-Protease active site unique compared to human proteases?

  • it is symmetrical → allows for selective drug targeting.

66
New cards

Which amino acids form the catalytic region of HIV-Protease?

  • Asp25, Thr26, Gly27 — located at the floor of the active site.

67
New cards

What is the role of the flap region in HIV-Protease?

  • Each monomer provides a flap that closes over the substrate once bound.

68
New cards

How many binding subsites does HIV-Protease have and which subsites are crucial for inhibitor interaction?

  • Eight total subsites: S4–S1 and S1'–S4' (four per monomer).

  • crucial - S2–S2' is key for binding and inhibition.

69
New cards

What type of peptide bond does HIV-Protease cleave?

  • Aromatic–proline bond, typically between phenylalanine or tyrosine and proline

70
New cards

Why is HIV-Protease selective compared to mammalian proteases?

  • Mammalian proteases do not cleave aromatic–proline bonds → allows selective inhibition.

71
New cards

Why are aspartic acids crucial in the catalytic mechanism of HIV protease?

  • bridge a water molecule that performs nucleophilic attack during amide bond hydrolysis.

72
New cards

What intermediate is formed during HIV-Protease catalysis?

  • A tetrahedral intermediate — representing the transition state of the reaction

73
New cards

What are the final products of HIV-Protease cleavage?

  • A carboxylic acid and an amine — resulting from peptide bond hydrolysis.

74
New cards

Why is the catalytic mechanism of HIV-Protease a key drug target?

  • inhibitors mimic the tetrahedral intermediate, blocking the enzyme’s function and halting viral maturation.

75
New cards

What is the design strategy behind HIV protease inhibitors?

  • they are designed as transition-state inhibitors to mimic the enzyme’s catalytic transition state.

76
New cards

Give an example of a HIV Protease inhibitor?

  • Saquinavir

77
New cards

What stereochemistry is essential for Saquinavir’s activity?

  • R-stereochemistry is crucial; S-configuration results in complete loss of activity.

78
New cards

What was the key design strategy used to improve Saquinavir’s potency?

  • stepwise optimization of binding groups and incorporation of a transition-state isostere to mimic the tetrahedral intermediate.

79
New cards

What are the disadvantages of Saquinavir?

  • high molecular weight and peptide character 

    • poor absorption, metabolic susceptibility, rapid excretion, limited access to CNS, high plasma protein binding = poor bioavailability 

  • susceptible to resistance development 

80
New cards

What is a limitation of using HIV protease inhibitors (PIs) alone?

  • like reverse transcriptase inhibitors, protease inhibitors offer short term benefit alone due to rapid resistance development 

81
New cards

How does combination therapy improve HIV treatment outcomes?

  • combing PIs and RTIs increases antiviral activity and slows resistance development 

82
New cards

What is the role of HIV integrase inhibitors in viral replication?

  • They block the integration of viral DNA into the host genome, halting HIV replication.

83
New cards

Name three HIV integrase inhibitors and their brand names.

  • Raltegravir (Isentress)

  • Elvitegravir (Stribild)

  • Dolutegravir (Tivicay)

84
New cards

Why are integrase inhibitors considered highly effective in HIV therapy?

  • They target a unique viral enzyme with minimal cross-reactivity to human enzymes → high selectivity and potency.

85
New cards

What is the mechanism of action of Raltegravir?

  • It chelates a divalent cation (Mn²⁺) at the active site of HIV integrase, blocking DNA integration.

86
New cards

Which structural feature of Raltegravir is crucial for metal chelation?

  • Coplanarity between the ketone and β-carbonyl enhances chelation of Mn²⁺.

87
New cards

What is the role of fusion inhibitors in HIV therapy?

  • they prevent HIV-1 from binding and fusing with host cells, blocking viral entry.

88
New cards

What is Maraviroc’s mechanism of action?

  • It acts as a CCR5 antagonist, blocking the coreceptor on host cells and preventing viral fusion.

89
New cards

What makes Maraviroc unique among anti-HIV drugs?

  • It targets a host cell protein (CCR5), not the virus itself — first of its kind.

90
New cards
91
New cards